Biocytogen Pharmaceuticals (Beijing) Co., Ltd., a biotechnology company, engages in the research and development of novel antibody-based drugs and pre-clinical...
Biocytogen, Whitehawk Therapeutics team up on bispecific antibody-drug conjugate development
Biocytogen Clarifies AGM Resolution on RMB1.5 Billion Credit Facilities and Guarantees
Biocytogen Pharmaceuticals Beijing Q1 Margin Expansion Reinforces Bullish Earnings Narratives
Biocytogen and Sihuan partner to advance new therapeutics for weight loss
CRO concept stocks fluctuated and strengthened, with Fushine and Menovo both hitting the daily limit, Kingchem rising more than 10%, and Biocytogen, BHC, and ChemPartner following suit
Biocytogen: Net profit is expected to increase by 384%-444% year-on-year in 2025